background
platelet
believ
critic
pulmonaryorigin
ard
mediat
endotheli
damag
interact
fi
brinogen
multipl
signal
transduct
pathway
prior
metaanalysi
identifi
five
loci
platelet
count
plt
bad
th
studi
aim
valid
quantit
trait
loci
qtl
plt
within
bad
among
critic
ill
patient
investig
associ
qtl
ard
risk
may
mediat
plt
ard
case
atrisk
control
subject
recruit
intens
care
unit
massachusett
gener
hospit
exomewid
genotyp
data
ard
case
atrisk
control
subject
genomewid
gene
express
profi
le
atrisk
control
subject
gener
analysi
singlenucleotid
polymorph
snp
within
signific
locu
plt
among
atrisk
control
subject
b
ci
p
th
associ
valid
use
gene
express
data
atrisk
control
subject
b
per
sd
increas
log
transform
express
ci
p
associ
ard
risk
condit
plt
ci
p
interact
plt
per
eff
ect
allel
per
l
plt
ci
p
mediat
plt
indirect
ci
p
fi
nding
support
role
platelet
format
suggest
import
ard
pathophysiolog
interact
mediat
platelet
abbrevi
ali
acut
lung
injuri
dic
dissemin
intravascular
coagul
maf
minor
allel
frequenc
mgh
massachusett
gener
hospit
plt
platelet
count
qc
qualiti
control
qtl
quantit
trait
locu
snp
singlenucleotid
polymorph
c
h
e
r
c
h
ard
character
acut
hypoxem
respiratori
failur
bilater
pulmonari
infi
ltrate
inhospit
mortal
rate
place
larg
burden
public
health
th
e
common
underli
caus
ard
includ
pulmonari
risk
factor
pneumonia
pulmonari
contus
nonpulmonari
risk
factor
includ
sepsi
burn
sever
trauma
multipl
transfus
studi
focus
role
genet
ard
pathophysiolog
identifi
ed
dozen
loci
relat
ard
outcom
eg
receptor
antagonist
angiopoietin
peptidas
inhibitor
protein
tyrosin
phosphatas
receptor
type
f
polypeptid
howev
role
genet
suscept
interact
microenvironment
factor
remain
incomplet
platelet
believ
make
import
contribut
pulmonaryorigin
ard
among
critic
ill
patient
act
conjunct
fi
brinogen
mediat
endotheli
damag
multipl
signal
transduct
pathway
inde
patient
ard
develop
thrombocytopenia
system
coagul
disord
platelet
consumpt
andor
dissemin
intravascular
coagul
dic
increas
risk
poor
prognosi
genet
factor
contribut
platelet
count
plt
begin
uncov
particular
metaanalysi
seven
genomewid
associ
studi
individu
seven
th
e
studi
review
approv
institut
review
board
massachusett
gener
hospit
mgh
harvard
school
public
health
project
approv
number
particip
surrog
care
provid
gave
written
inform
consent
ard
case
control
subject
identifi
critic
ill
patient
icu
mgh
describ
previous
briefl
screen
icu
admiss
elig
subject
defi
ned
critic
ill
patient
least
one
predispos
condit
ard
sepsi
septic
shock
trauma
pneumonia
aspir
massiv
transfus
pack
rbc
defi
ned
pack
rbc
unit
h
admiss
without
exclus
criteria
age
year
diff
use
alveolar
hemorrhag
chronic
lung
diseas
copd
asthma
direct
withhold
intub
immunosuppress
secondari
corticosteroid
treatment
granulocyt
colonystimul
factor
aft
er
enrol
subject
follow
daili
develop
ard
defi
ned
americaneuropean
consensu
committe
control
subject
identifi
ed
atrisk
patient
meet
criteria
ard
icu
stay
prior
histori
ard
patient
demograph
baselin
clinic
characterist
includ
sepsi
pneumonia
trauma
transfus
plt
collect
icu
admiss
genotyp
dna
extract
peripher
wbc
use
protocol
describ
previous
subject
genotyp
use
infi
nium
humanexom
beadchip
illumina
inc
analysi
systemat
qualiti
evalu
conduct
raw
genotyp
data
accord
gener
qualiti
control
qc
procedur
describ
anderson
colleagu
briefl
unqualifi
ed
sampl
exclud
fi
follow
qc
criteria
overal
genotyp
complet
rate
sex
discrep
unexpect
duplic
probabl
rel
base
pairwis
ident
state
valu
pihat
plink
heterozygos
rate
six
time
sd
mean
unqualifi
ed
snp
exclud
fi
follow
qc
criteria
snp
call
rate
sampl
genotyp
distri
bution
snp
deviat
expect
hardyweinberg
equilibrium
p
snp
rare
detect
variant
sampl
size
aft
er
qualiti
evalu
ard
case
atrisk
control
subject
snp
includ
initi
analys
valid
studi
genomewid
gene
express
profi
le
gener
total
rna
sampl
extract
peripher
blood
collect
icu
admiss
atrisk
control
subject
mgh
ard
studi
cohort
protocol
sampl
collect
process
whole
populationbas
cohort
identifi
ed
fi
quantit
trait
loci
qtl
associ
plt
bad
although
identifi
cation
loci
provid
foundat
understand
genet
contribut
plt
studi
yet
examin
role
pltassoci
loci
ard
pathophysiolog
hypothesi
plt
may
act
import
causal
mediat
genet
eff
ect
ard
develop
causal
infer
mediat
model
rigor
approach
identifi
explain
mechan
independ
variabl
eg
genet
variant
aff
ect
outcom
eg
ard
risk
via
third
explanatori
variabl
known
mediat
variabl
eg
plt
fig
th
approach
success
appli
research
sever
lung
diseas
use
exomewid
genotyp
data
illumina
exomechip
studi
valid
qtl
plt
within
fi
candid
genesbad
among
critic
ill
patient
evalu
fi
nding
independ
gene
express
experiment
data
final
explor
eff
ect
genet
variant
ard
risk
whether
eff
ect
causal
mediat
plt
blood
total
rna
extract
qualiti
assess
describ
previous
rna
sampl
hybrid
aff
ymetrix
genechip
aff
ymetrix
inc
express
valu
four
probe
set
within
extract
normal
log
transform
use
dchip
soft
ware
th
ree
probe
set
exclud
analysi
absent
call
sampl
one
probe
set
includ
analysi
baselin
characterist
includ
demograph
baselin
measur
describ
mean
sd
minimum
maximum
continu
variabl
number
categor
variabl
th
e
student
test
fisher
exact
test
use
comparison
group
continu
categor
variabl
respect
snp
encod
addit
genet
format
wild
type
heterozygos
homozygos
minor
allel
eff
ect
allel
th
studi
includ
three
main
scenario
analys
predefi
ned
order
qtl
analysi
plt
ard
risk
analysi
snp
variant
causal
infer
analysi
th
e
sequenti
test
strategyborrow
serial
gatekeep
procedurewa
use
analysi
would
move
forward
previou
one
reach
reason
signifi
canc
th
strategi
broadli
use
control
familywis
type
error
clinic
trial
multipl
comparison
predefi
ned
sequenc
model
adjust
covari
age
sex
sepsi
pneumonia
admiss
unless
state
otherwis
th
e
sequenc
kernel
associ
test
use
genebas
qtl
analysi
th
e
log
transform
gene
express
standard
z
score
z
qtl
analysi
use
linear
regress
th
e
result
indic
b
coeffi
cient
explain
chang
plt
per
sd
increas
log
transform
express
level
ci
snplevel
qtl
analysi
linear
regress
use
analyz
fi
common
snp
respect
th
e
result
indic
b
coeffici
chang
plt
per
eff
ect
allel
snp
ci
th
e
snp
fals
discoveri
rate
describ
q
valu
select
ard
risk
analysi
one
snp
reach
criteria
th
e
proport
plt
varianc
explain
snp
estim
use
analysi
varianc
ratio
sum
squar
snp
ss
snp
sum
squar
total
ss
total
ard
risk
analysi
associ
snp
plt
interact
ard
risk
evalu
logist
regress
describ
exponenti
function
coeffi
cient
ci
u
snp
u
plt
u
interact
repres
coeffi
cient
snp
plt
snpplt
interact
respect
b
vector
coeffi
cient
covari
th
e
analysi
would
move
forward
statist
p
valu
u
snp
u
interact
test
causal
infer
analysi
vanderweel
mediat
model
appli
evalu
causal
indirect
eff
ect
snp
mediat
plt
th
e
result
describ
indirect
indirect
per
eff
ect
allel
snp
ci
b
snp
estim
follow
weight
linear
regress
model
plt
snp
model
weight
w
calcul
case
control
subject
respect
preval
repres
preval
ard
among
atrisk
critic
ill
popul
r
repres
proport
ard
case
analyt
dataset
bootstrap
replic
use
estim
ci
indirect
statist
signifi
canc
th
e
imai
causal
infer
method
also
use
weight
crossvalid
vanderweel
mediat
model
statist
signifi
canc
level
analys
perform
use
r
statist
soft
ware
v
th
e
r
foundat
th
e
distribut
demograph
clinic
characterist
icu
admiss
among
patient
ard
atrisk
control
subject
describ
tabl
control
subject
ard
case
white
signifi
cant
diff
erenc
observ
age
sex
distribut
ard
atrisk
control
group
plt
number
subject
sepsi
pneumonia
risk
factor
ard
signifi
cantli
diff
erent
case
control
subject
sinc
design
illumina
exomechip
focus
function
exon
snp
cover
snp
either
lowfrequ
rare
allel
minor
allel
frequenc
maf
snp
map
within
bad
two
rare
snp
map
within
exclud
analysi
ensur
adequ
statist
power
th
e
snp
identifi
ed
within
includ
analysi
tabl
th
e
analysi
workfl
ow
describ
figur
initi
conduct
genebas
qtl
analysi
plt
genet
variant
tabl
five
common
snp
maf
show
signifi
cant
joint
associ
plt
among
atrisk
control
subject
p
valid
fi
nding
use
independ
wholegenom
gene
express
data
atrisk
control
subject
linear
regress
model
detect
signifi
cant
associ
express
level
plt
b
per
sd
increas
express
level
ci
p
fig
aft
er
adjust
common
covari
includ
age
sex
sepsi
pneumonia
use
stepwis
regress
associ
remain
signifi
cant
p
perform
singl
snp
qtl
analysi
common
snp
within
tabl
snp
signifi
cantli
associ
plt
among
atrisk
control
subject
b
per
eff
ect
allel
snp
ci
p
fals
discoveri
rate
adjust
q
valu
explain
around
plt
varianc
evalu
potenti
confound
sensit
analysi
adjust
covari
tabl
snp
signifi
cant
qtl
marker
plt
tabl
associ
ard
risk
interact
plt
tabl
plt
may
act
import
causal
mediat
genet
effect
ard
outcom
test
hypothesi
perform
causal
infer
test
use
mediat
analysi
base
previous
report
studi
consid
case
berlin
moder
sever
ard
ard
preval
among
atrisk
popul
set
turn
use
calcul
weight
mediat
analysi
signifi
cant
causal
indirect
eff
ect
detect
snp
increas
risk
ard
mediat
plt
vanderweel
method
indirect
per
eff
ect
allel
ci
p
tabl
signifi
canc
confi
rmed
imai
method
p
tabl
also
perform
two
sensit
analys
exclud
control
subject
could
reclassifi
ed
patient
ali
exclud
ard
case
diagnos
day
icu
admiss
consist
signific
borderlin
signifi
cant
associ
observ
tabl
evalu
impact
diff
erent
ard
preval
result
set
ard
preval
sensit
analys
result
consist
ard
preval
tabl
genet
variant
within
previous
report
associ
plt
among
rel
healthi
african
american
popul
studi
replic
result
valid
associ
common
intron
snp
g
allel
frequenc
within
plt
white
popul
critic
ill
patient
th
e
snp
show
limit
popul
divers
nation
center
biotechnolog
inform
dbsnp
databas
g
allel
frequenc
african
american
interestingli
among
ard
case
atrisk
control
subject
associ
inconsist
th
e
mechan
well
understood
possibl
play
diff
erent
role
atrisk
control
subject
vs
ard
case
need
studi
studi
demonstr
strong
evid
low
platelet
count
contribut
higher
risk
ard
low
plt
could
caus
thrombocytopenia
dic
common
complic
among
critic
ill
patient
independ
risk
factor
aff
ect
prognosi
howev
could
rule
role
low
platelet
ard
pathophysiolog
platelet
consumpt
dic
notabl
result
suggest
play
import
role
ard
risk
mediat
plt
th
e
indirect
hazard
eff
ect
snp
ard
risk
may
explain
snp
caus
regress
coeffi
cient
ci
repres
chang
plt
per
eff
ect
allel
c
q
repres
adjust
p
valu
fals
discoveri
rate
method
p
also
known
total
eff
ect
mediat
analysi
possibl
signifi
cant
indirect
eff
ect
absenc
total
eff
ect
th
explain
presenc
sever
mediat
path
multipl
potenti
mediat
confl
ict
becom
notic
one
cancel
mediat
control
th
us
indirect
eff
ect
identifi
ed
studi
partial
mediat
eff
ect
howev
mechan
need
better
understood
wellcontrol
experi
also
interact
plt
impli
eff
ect
beyond
platelet
count
also
function
turn
ard
risk
extens
evid
demonstr
role
platelet
function
increas
morbid
mortal
among
patient
icu
wherea
precis
mechan
genet
variant
impact
platelet
turn
aff
ect
ard
risk
requir
studi
function
genom
encod
cap
protein
myosini
linker
carmil
cytoskelet
scaff
old
protein
bind
cap
protein
muscl
zline
high
affi
niti
signifi
cantli
decreas
affi
niti
actin
barb
end
b
subunit
barbedend
actin
bind
protein
heterodimer
actincap
protein
block
actin
fi
lament
factin
assembl
disassembl
fastgrow
barb
fi
lament
end
function
regul
actin
fi
lament
dynam
well
stabil
actin
fi
lament
actinbas
cellular
process
essenti
endamplifi
cation
proplatelet
process
megakaryocyt
matur
th
e
intron
snp
may
linkag
disequilibrium
latent
function
variant
alter
activ
carmil
therebi
result
abnorm
megakaryocyt
matur
alter
platelet
format
interestingli
platelet
contain
actinbind
protein
bind
shorten
actin
fi
lament
moreov
factin
act
key
step
ard
induc
system
infl
ammatori
respons
syndrom
via
increas
blood
neutrophil
adhes
migrat
product
infl
ammatori
factor
altern
postul
mechan
ard
platelet
independ
variant
prevent
actin
polymer
impact
alveolar
capillari
barrier
function
acknowledg
limit
studi
th
e
illumina
exomechip
includ
high
percentag
lowfrequ
allel
studi
limit
power
studi
associ
lowfrequ
function
snp
ard
outcom
addit
investig
need
evalu
mechan
underli
mediat
platelet
associ
genet
variant
risk
ard
consid
heterogen
variou
manifest
ard
studi
result
examin
even
larger
sampl
evalu
fi
nding
among
specifi
c
subgroup
anoth
limit
attribut
causal
sole
base
result
mediat
analysi
requir
followup
welldesign
function
studi
summari
valid
associ
platelet
count
among
critic
ill
patient
fi
nding
suggest
play
import
role
ard
pathophysiolog
interact
causal
mediat
platelet
